Cutaneous adverse-events in patients treated with Ibrutinib.
Pileri A, Guglielmo A, Agostinelli C, Evangelista V, Bertuzzi C, Alessandrini A, Bruni F, Starace M, Massi A, Broccoli A, Patrizi A, Zinzani PL, Piraccini BM.
Pileri A, et al. Among authors: guglielmo a.
Dermatol Ther. 2020 Nov;33(6):e14190. doi: 10.1111/dth.14190. Epub 2020 Sep 27.
Dermatol Ther. 2020.
PMID: 32790083